Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Michael Young who wrote (24142)	7/18/2007 3:09:07 PM
From: Biomaven	Read Replies (3) \| Respond to of 52153

Lipitor sales in the U.S. fell 25% to $1.38 billion compared with the year-earlier period. Yes, you called this one correctly. Finally here's proof that rkrw is not actually completely infallible (as most of us heretofore believed): <g> I'm leaning on your side. Pfizer will just raise their prices to make up for any small decline in rx. So I'd predict flat to plus a few % sales on a dollar basis. Maybe a low single digit decline on an rx basis. Message 22543386 Here was my take earlier: All I know is my health insurer (Blue Cross handled through Express Scripts) went so far as to send me a partially-filled-out Zocor script for me to give to my doctor. They did show enough restraint not to fill out what dosage they thought I should be taking. :) Peter